Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting

OBJECTIVES: Biological products have contributed to extraordinary advances in disease treatments over the last decade. However, the cost-saving potential of imitator products, so-called biosimilars, is still under-researched in Switzerland. This study aims to assess biosimilars’ prescriptions at tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirth, Kevin, Boes, Stefan, Näpflin, Markus, Huber, Carola, Blozik, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668177/
https://www.ncbi.nlm.nih.gov/pubmed/37989386
http://dx.doi.org/10.1136/bmjopen-2023-077454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668177/
https://www.ncbi.nlm.nih.gov/pubmed/37989386
http://dx.doi.org/10.1136/bmjopen-2023-077454

Ejemplares similares